J&J | JNJ - Assets

Stock Price
237.70
Daily Change
3.23 1.38%
Monthly
16.07%
Yearly
54.84%
Q1 Forecast
220.25

J&J reported $192.82B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
AbbVie USD 133.9B 3.28B Sep/2025
Abbott USD 84.18B 182M Sep/2025
Amgen USD 90.14B 2.24B Sep/2025
AstraZeneca USD 114.46B 2.03B Sep/2025
Baxter International USD 21.07B 21M Sep/2025
Bayer EUR 104.21B 1.03B Sep/2025
Becton, Dickinson and Co. USD 55.32B 423M Sep/2025
Biogen USD 29.21B 877.3M Sep/2025
Boston Scientific USD 42.71B 1.15B Sep/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
CONMED USD 2.32B 5.97M Sep/2025
Cooper Companies USD 12.39B 18.1M Sep/2025
Dexcom USD 7.5B 173M Sep/2025
Edwards Lifesciences USD 13.27B 216.5M Sep/2025
Eli Lilly USD 114.94B 14.01B Sep/2025
Gilead Sciences USD 58.53B 2.81B Sep/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
Globus Medical USD 5.1B 134.55M Sep/2025
Hologic USD 9.18B 165.8M Dec/2025
Insulet USD 3.03B 439.9M Sep/2025
Integra LifeSciences USD 3.65B 21.45M Sep/2025
Intuitive Surgical USD 20.46B 1.11B Dec/2025
J&J USD 192.82B 573M Sep/2025
Medtronic USD 90.97B 708M Jun/2025
Merck USD 129.55B 12.02B Sep/2025
Merit Medical Systems USD 2.63B 44.95M Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
Regeneron Pharmaceuticals USD 40.56B 389.3M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 126.81B 2.99B Dec/2025
Stryker USD 47.84B 787M Dec/2025
Tandem Diabetes Care USD 874.65M 1.08M Sep/2025
Teva Pharmaceutical Industries USD 40.75B 892M Dec/2025
Vertex Pharmaceuticals USD 24.86B 825.6M Sep/2025
Zimmer Biomet Holdings USD 23.49B 622.9M Sep/2025
Zoetis USD 15.16B 680M Sep/2025